Matching resources to treatment decisions for patients with acute coronary syndromes
1Duke Clinical Research Institute, Duke University Medical Center, Durham, North Carolina 27705-3076, USA. calif001@mc.duke.edu
Insights
Cardiovascular disease treatment is evolving due to longer lifespans and medical advancements, increasing healthcare costs and emphasizing evidence-based medicine and patient involvement. Acute coronary syndrome therapies face scrutiny.
Area of Science:
- Cardiovascular Medicine
- Health Services Research
Background:
- Cardiovascular disease (CVD) treatment is influenced by demographic shifts like increased life expectancy and reduced disability.
- Technological advancements are improving medical effectiveness but contributing to rising healthcare costs.
- Growing healthcare consumerism empowers patients in treatment decisions.
Purpose of the Study:
- To examine the dynamic forces shaping current and future cardiovascular disease treatment.
- To highlight the increasing importance of evidence-based medicine and quality measurement in cardiology.
- To underscore the need for value-based care, balancing quality and cost, independent of future genomic advancements.
Main Methods:
- This is a conceptual analysis and synthesis of current trends in cardiovascular medicine.
- It involves reviewing the impact of demographic, technological, and patient-driven factors on healthcare delivery.
- The analysis considers the evolving landscape of quality definition, measurement, and accountability in healthcare.
Main Results:
- Multiple factors are converging to reshape cardiovascular care, necessitating a focus on value.
- Evidence-based medicine is paramount, with payers and government demanding defined and measured quality.
- Acute coronary syndrome (ACS) treatments will face heightened scrutiny due to extensive available evidence.
Conclusions:
- The future of cardiovascular medicine requires a proactive approach to delivering high-quality, cost-effective care.
- Genomic advancements, while important, should not delay the implementation of value-based healthcare principles.
- Increased accountability for quality outcomes is a defining characteristic of modern cardiovascular practice.
Abstract:
Multiple dynamic forces are having an impact on the way cardiovascular disease is treated today and will be in the future. These forces include extended life expectancy, decreased disability, and accelerated improvement in the effectiveness of medical technology. All of these forces will lead to a predictable increase in health care costs. Cardiologists must also be cognizant of the rise in health care consumerism; patients are assuming a larger role in decisions about their medical care and treatment. All of these factors are driving the climate of evidence-based medicine, particularly in the cardiovascular field. Payers and the government are beginning to require the clinical community to define quality. In turn, these third parties are beginning to measure quality as defined by the profession and to hold providers accountable for the quality of what they do. Although the frontier of genetic prediction in therapeutics will serve as an intellectual focus for bringing these issues closer to the forefront in cardiovascular medicine, the fundamental provision of value in health care (high quality at reasonable cost) cannot wait on genomics. Because the amount of evidence in acute coronary syndromes (ACS) exceeds other areas of medicine, therapies for ACS will undergo increasingly intense scrutiny.
Related Concept Videos
01:28Acute Coronary Syndrome IV: Interprofessional Care
01:30Acute Coronary Syndrome III: Diagnostic Studies
01:30Acute Coronary Syndrome I: Introduction
01:27Coronary Artery Disease V: Interprofessional Care
01:26Acute Coronary Syndrome V: Nursing Management
01:20Angina V: Nursing Management